TThe Institute of Physiology of the Czech Academy of Sciences (IPHYS) is one of the leading research institutions in the Czech Republic (http://fgu.cas.cz). Its primary mission is to elucidate the mechanisms underlying the development of major human diseases, including vascular and cerebrovascular disorders, ischemic heart disease, diabetes, hereditary metabolic disorders, and neurodegenerative diseases. Francesc Villarroya has been appointed as a member of the IPHYS International Advisory Board (IAB-IPHYS), an independent body composed of five internationally recognized scientists. The board’s main objective is to support the development of IPHYS’s research strategy, enhance its international collaboration and visibility, and promote its participation in large-scale international projects.